$DFFN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Diffusion Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Diffusion Pharmaceuticals Inc.. Get notifications about new insider transactions in Diffusion Pharmaceuticals Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 04 2021 | DFFN | Diffusion Pharmace ... | Cobuzzi Robert Joseph Jr. | President & CEO | Option Exercise | A | 1.11 | 161,139 | 178,864 | 161,139 | |
Mar 04 2021 | DFFN | Diffusion Pharmace ... | Cobuzzi Robert Joseph Jr. | President & CEO | Option Exercise | A | 1.11 | 53,713 | 59,621 | 53,713 | |
Mar 04 2021 | DFFN | Diffusion Pharmace ... | ELDER WILLIAM ROBERT | GC & Secretary | Option Exercise | A | 1.11 | 62,522 | 69,399 | 62,522 | |
Mar 04 2021 | DFFN | Diffusion Pharmace ... | ELDER WILLIAM ROBERT | GC & Secretary | Option Exercise | A | 1.11 | 87,684 | 97,329 | 87,684 | |
Mar 04 2021 | DFFN | Diffusion Pharmace ... | GALLOWAY CHRISTOPHER D | Chief Medical Offic ... | Option Exercise | A | 1.11 | 81,537 | 90,506 | 81,537 | |
Mar 04 2021 | DFFN | Diffusion Pharmace ... | GALLOWAY CHRISTOPHER D | Chief Medical Offic ... | Option Exercise | A | 1.11 | 27,180 | 30,170 | 27,180 | |
Mar 04 2021 | DFFN | Diffusion Pharmace ... | Hornung William Karl | Chief Financial Off ... | Option Exercise | A | 1.11 | 80,069 | 88,877 | 80,069 | |
Mar 04 2021 | DFFN | Diffusion Pharmace ... | Hornung William Karl | Chief Financial Off ... | Option Exercise | A | 1.11 | 122,771 | 136,276 | 122,771 | |
Nov 18 2020 | DFFN | Diffusion Pharmace ... | Cobuzzi Robert Joseph Jr. | President & CEO | Buy | P | 0.66 | 14,000 | 9,240 | 14,000 | 0 to 14 K |
Oct 21 2020 | DFFN | Diffusion Pharmace ... | GALLOWAY CHRISTOPHER D | Chief Medical Offic ... | Option Exercise | A | 0.85 | 200,000 | 170,000 | 200,000 | |
Oct 01 2020 | DFFN | Diffusion Pharmace ... | Hollingsworth Jane H | Director | Option Exercise | A | 0.00 | 54,900 | 0 | 54,900 | |
Oct 01 2020 | DFFN | Diffusion Pharmace ... | Hollingsworth Jane H | Director | Option Exercise | A | 0.91 | 67,400 | 61,334 | 67,400 | |
Sep 11 2020 | DFFN | Diffusion Pharmace ... | Cobuzzi Robert Joseph Jr. | President & CEO | Option Exercise | A | 0.79 | 475,000 | 375,250 | 475,000 | |
Jun 18 2020 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 1.00 | 61,300 | 61,300 | 61,300 | |
Jun 18 2020 | DFFN | Diffusion Pharmace ... | Cobuzzi Robert Joseph Jr. | Director | Option Exercise | A | 1.00 | 61,300 | 61,300 | 61,300 | |
Jun 18 2020 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 1.00 | 61,300 | 61,300 | 61,300 | |
Jun 18 2020 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 1.00 | 61,300 | 61,300 | 61,300 | |
Jun 18 2020 | DFFN | Diffusion Pharmace ... | Cobuzzi Robert Joseph Jr. | Director | Option Exercise | A | 1.00 | 61,300 | 61,300 | 61,300 | |
Jun 18 2020 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 1.00 | 61,300 | 61,300 | 61,300 | |
Jun 18 2020 | DFFN | Diffusion Pharmace ... | LEVIN ALAN G | Director | Option Exercise | A | 1.00 | 61,300 | 61,300 | 61,300 | |
Jan 30 2020 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 0.46 | 239,400 | 110,124 | 239,400 | |
Jan 30 2020 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.46 | 262,900 | 120,934 | 262,900 | |
Jan 30 2020 | DFFN | Diffusion Pharmace ... | Hornung William Karl | Chief Financial Off ... | Option Exercise | A | 0.46 | 52,600 | 24,196 | 52,600 | |
Jan 13 2020 | DFFN | Diffusion Pharmace ... | Cobuzzi Robert Joseph Jr. | Director | Option Exercise | A | 0.51 | 98,100 | 50,031 | 98,100 | |
Jan 13 2020 | DFFN | Diffusion Pharmace ... | Cobuzzi Robert Joseph Jr. | Director | Option Exercise | A | 0.42 | 118,600 | 49,812 | 118,600 | |
Jan 09 2020 | DFFN | Diffusion Pharmace ... | Byrne Thomas E | General Counsel | Option Exercise | A | 0.42 | 25,000 | 10,500 | 25,000 | |
Jul 19 2019 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 3.15 | 13,100 | 41,265 | 13,100 | |
Jul 19 2019 | DFFN | Diffusion Pharmace ... | LEVIN ALAN G | Director | Option Exercise | A | 3.15 | 13,100 | 41,265 | 13,100 | |
Jul 19 2019 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 3.15 | 13,100 | 41,265 | 13,100 | |
Jan 30 2019 | DFFN | Diffusion Pharmace ... | Byrne Thomas E | General Counsel | Option Exercise | A | 2.10 | 2,667 | 5,601 | 2,667 | |
Jan 04 2019 | DFFN | Diffusion Pharmace ... | Hornung William Karl | Chief Financial Off ... | Option Exercise | A | 2.10 | 16,334 | 34,301 | 16,334 | |
Jun 18 2018 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 0.54 | 40,000 | 21,600 | 40,000 | |
Jun 18 2018 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 0.54 | 40,000 | 21,600 | 40,000 | |
Jun 18 2018 | DFFN | Diffusion Pharmace ... | LEVIN ALAN G | Director | Option Exercise | A | 0.54 | 40,000 | 21,600 | 40,000 | |
Jun 18 2018 | DFFN | Diffusion Pharmace ... | RUFFOLO ROBERT R | Director | Option Exercise | A | 0.54 | 40,000 | 21,600 | 40,000 | |
Jan 04 2018 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 1.18 | 45,000 | 53,100 | 45,000 | |
Jan 04 2018 | DFFN | Diffusion Pharmace ... | RUFFOLO ROBERT R | Director | Option Exercise | A | 1.18 | 25,000 | 29,500 | 25,000 | |
Jan 04 2018 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 1.18 | 55,000 | 64,900 | 55,000 | |
Jan 04 2018 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 1.18 | 25,000 | 29,500 | 25,000 | |
Jan 04 2018 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 1.18 | 25,000 | 29,500 | 25,000 | |
Jul 13 2017 | DFFN | Diffusion Pharmace ... | RUFFOLO ROBERT R | Director | Option Exercise | A | 2.31 | 52,057 | 120,252 | 52,057 | |
Jun 16 2017 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 2.40 | 23,900 | 57,360 | 23,900 | |
Jun 16 2017 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 2.40 | 23,900 | 57,360 | 23,900 | |
Jun 16 2017 | DFFN | Diffusion Pharmace ... | LEVIN ALAN G | Director | Option Exercise | A | 2.40 | 23,900 | 57,360 | 23,900 | |
May 12 2017 | DFFN | Diffusion Pharmace ... | Shealy Ben | Sr VP Finance & Tre ... | Option Exercise | A | 2.95 | 23,100 | 68,145 | 23,100 | |
May 12 2017 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 2.95 | 34,000 | 100,300 | 34,000 | |
May 12 2017 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 2.95 | 41,000 | 120,950 | 41,000 | |
Jan 04 2017 | DFFN | Diffusion Pharmace ... | Byrne Thomas E | General Counsel | Option Exercise | A | 2.26 | 4,673 | 10,561 | 4,673 | |
Dec 28 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Buy | P | 0.00 | 290,580 | 0 | 802,689 | 512.1 K to 802.7 K (+56.74 %) |
Dec 28 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Sell | J | 0.00 | 290,580 | 0 | 0 | 290.6 K to 0 (-100.00 %) |
Dec 16 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Buy | P | 0.00 | 512,109 | 0 | 512,109 | 0 to 512.1 K |
Dec 16 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Sell | J | 0.00 | 339,055 | 0 | 290,580 | 629.6 K to 290.6 K (-53.85 %) |
Dec 13 2016 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 2.74 | 14,000 | 38,360 | 14,000 | |
Dec 13 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 2.74 | 34,000 | 93,160 | 34,000 | |
Dec 13 2016 | DFFN | Diffusion Pharmace ... | Shealy Ben | Sr VP Finance & Tre ... | Option Exercise | A | 2.74 | 16,000 | 43,840 | 16,000 | |
Dec 13 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 2.74 | 14,000 | 38,360 | 14,000 | |
Dec 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 2.74 | 105,000 | 287,700 | 105,000 | |
Dec 13 2016 | DFFN | Diffusion Pharmace ... | LEVIN ALAN G | Director | Option Exercise | A | 2.74 | 14,000 | 38,360 | 14,000 | |
Sep 16 2016 | DFFN | Diffusion Pharmace ... | BLECH ISAAC | Director | Option Exercise | A | 8.00 | 204,907 | 1,639,256 | 204,907 | |
Jul 25 2016 | DFFN | Diffusion Pharmace ... | LEVIN ALAN G | Director | Option Exercise | A | 0.90 | 58,473 | 52,626 | 58,473 | |
Jul 25 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 0.90 | 58,473 | 52,626 | 58,473 | |
Jul 25 2016 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 0.90 | 58,473 | 52,626 | 58,473 | |
May 20 2016 | DFFN | Diffusion Pharmace ... | Byrne Thomas E | General Counsel | Option Exercise | A | 0.96 | 16,667 | 16,000 | 16,667 | |
May 20 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.96 | 204,167 | 196,000 | 204,167 | |
May 20 2016 | DFFN | Diffusion Pharmace ... | Shealy Ben | Senior Vice Preside ... | Option Exercise | A | 0.96 | 89,583 | 86,000 | 89,583 | |
May 20 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 0.96 | 83,333 | 80,000 | 83,333 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.55 | 331,595 | 182,377 | 331,595 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.55 | 365,265 | 200,896 | 365,265 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.42 | 127,843 | 53,694 | 127,843 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.42 | 182,632 | 76,705 | 182,632 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.62 | 182,632 | 113,232 | 182,632 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.35 | 127,843 | 44,745 | 127,843 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.22 | 273,949 | 60,269 | 273,949 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.22 | 91,316 | 20,090 | 91,316 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Option Exercise | A | 0.22 | 295,865 | 65,090 | 295,865 | |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Grant | A | 0.00 | 215,506 | 0 | 215,506 | 0 to 215.5 K |
Jan 13 2016 | DFFN | Diffusion Pharmace ... | Kalergis David G | Chairman and CEO | Grant | A | 0.00 | 1,069,216 | 0 | 1,069,216 | 0 to 1.1 M |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Byrne Thomas S | Director | Option Exercise | A | 0.55 | 237,422 | 130,582 | 237,422 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Byrne Thomas S | Director | Option Exercise | A | 0.55 | 365,265 | 200,896 | 365,265 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Byrne Thomas S | Director | Option Exercise | A | 0.42 | 182,632 | 76,705 | 182,632 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Byrne Thomas S | Director | Option Exercise | A | 0.42 | 182,632 | 76,705 | 182,632 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Byrne Thomas S | Director | Option Exercise | A | 0.62 | 182,632 | 113,232 | 182,632 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Byrne Thomas S | Director | Option Exercise | A | 0.35 | 36,526 | 12,784 | 36,526 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Byrne Thomas S | Director | Option Exercise | A | 0.22 | 109,579 | 24,107 | 109,579 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Byrne Thomas S | Director | Option Exercise | A | 0.22 | 91,316 | 20,090 | 91,316 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Byrne Thomas S | Director | Option Exercise | A | 0.22 | 215,506 | 47,411 | 215,506 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Byrne Thomas S | Director | Grant | A | 0.00 | 1,391,867 | 0 | 1,391,867 | 0 to 1.4 M |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 0.55 | 365,265 | 200,896 | 365,265 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 0.42 | 182,632 | 76,705 | 182,632 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 0.62 | 182,632 | 113,232 | 182,632 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 0.22 | 91,316 | 20,090 | 91,316 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Option Exercise | A | 0.22 | 186,285 | 40,983 | 186,285 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Grant | A | 0.00 | 188,973 | 0 | 188,973 | 0 to 189 K |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Adams Robert W | Director | Grant | A | 0.00 | 350,504 | 0 | 350,504 | 0 to 350.5 K |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 0.55 | 365,265 | 200,896 | 365,265 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 0.42 | 182,632 | 76,705 | 182,632 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 0.62 | 182,632 | 113,232 | 182,632 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 0.22 | 91,316 | 20,090 | 91,316 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Option Exercise | A | 0.22 | 98,621 | 21,697 | 98,621 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Grant | A | 0.00 | 6,296,346 | 0 | 6,296,346 | 0 to 6.3 M |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Giles Mark T | Director | Grant | A | 0.00 | 44,069 | 0 | 44,069 | 0 to 44.1 K |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | LEVIN ALAN G | Director | Option Exercise | A | 0.55 | 365,265 | 200,896 | 365,265 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | LEVIN ALAN G | Director | Option Exercise | A | 0.42 | 276,140 | 115,979 | 276,140 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | LEVIN ALAN G | Director | Grant | A | 0.00 | 248,032 | 0 | 248,032 | 0 to 248 K |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 0.55 | 219,159 | 120,537 | 219,159 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 0.55 | 365,265 | 200,896 | 365,265 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 0.42 | 109,579 | 46,023 | 109,579 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 0.42 | 182,632 | 76,705 | 182,632 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 0.35 | 91,316 | 31,961 | 91,316 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 0.62 | 182,632 | 113,232 | 182,632 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 0.22 | 182,632 | 40,179 | 182,632 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 0.22 | 91,316 | 20,090 | 91,316 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Option Exercise | A | 0.22 | 226,486 | 49,827 | 226,486 | |
Jan 12 2016 | DFFN | Diffusion Pharmace ... | Gainer John | Chief Scientific Of ... | Grant | A | 0.00 | 3,725,711 | 0 | 3,725,711 | 0 to 3.7 M |
Sep 21 2015 | DFFN | Diffusion Pharmace ... | BLECH ISAAC | Director | Option Exercise | A | 3.00 | 17,441 | 52,323 | 17,441 | |
Aug 06 2014 | DFFN | Diffusion Pharmace ... | Weinberg Mark A. | Sr. V.P.- Clinical ... | Option Exercise | A | 3.90 | 521,475 | 2,033,753 | 521,475 | |
Jul 29 2014 | DFFN | Diffusion Pharmace ... | STACKS NELSON K. | Director | Option Exercise | A | 3.92 | 61,374 | 240,586 | 61,374 | |
Jul 29 2014 | DFFN | Diffusion Pharmace ... | SIMES STEPHEN M | Chief Executive Off ... | Option Exercise | A | 3.92 | 542,975 | 2,128,462 | 542,975 | |
Jul 29 2014 | DFFN | Diffusion Pharmace ... | SHERRIS DAVID | Chief Scientific Of ... | Option Exercise | A | 3.92 | 119,482 | 468,369 | 119,482 | |
Jul 29 2014 | DFFN | Diffusion Pharmace ... | Schwartz Yael | Exe. VP Preclinical ... | Option Exercise | A | 3.92 | 119,482 | 468,369 | 119,482 | |
Jul 29 2014 | DFFN | Diffusion Pharmace ... | DONENBERG PHILIP B | Director | Option Exercise | A | 3.92 | 271,475 | 1,064,182 | 271,475 | |
Jul 29 2014 | DFFN | Diffusion Pharmace ... | Bright Rex | Director | Option Exercise | A | 3.92 | 61,085 | 239,453 | 61,085 | |
Jul 29 2014 | DFFN | Diffusion Pharmace ... | Boris Timothy | Director | Option Exercise | A | 3.92 | 79,655 | 312,248 | 79,655 | |
Jul 29 2014 | DFFN | Diffusion Pharmace ... | BLECH ISAAC | Director | Option Exercise | A | 3.92 | 87,449 | 342,800 | 87,449 | |
Jul 29 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Director | Option Exercise | A | 3.92 | 123,287 | 483,285 | 123,287 | |
Jun 12 2014 | DFFN | Diffusion Pharmace ... | SHERRIS DAVID | CSO & President of ... | Option Exercise | A | 4.15 | 115,193 | 478,051 | 115,193 | |
Jun 12 2014 | DFFN | Diffusion Pharmace ... | Abolin Craig | VP of Research & De ... | Option Exercise | A | 4.15 | 57,596 | 239,023 | 57,596 | |
Jun 12 2014 | DFFN | Diffusion Pharmace ... | Schwartz Yael | President of Subsid ... | Option Exercise | A | 4.15 | 115,193 | 478,051 | 115,193 | |
Jun 10 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Chairman of the Boa ... | Option Exercise | A | 2.00 | 95,170 | 190,340 | 95,170 | |
Jun 10 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Chairman of the Boa ... | Option Exercise | C | 0.00 | 126,894 | 0 | 0 | |
Jun 10 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Chairman of the Boa ... | Option Exercise | A | 2.00 | 57,566 | 115,132 | 57,566 | |
Jun 10 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Chairman of the Boa ... | Option Exercise | C | 0.00 | 76,755 | 0 | 0 | |
Jun 10 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Chairman of the Boa ... | Option Exercise | C | 0.00 | 78,473 | 0 | 0 | |
Jun 10 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Chairman of the Boa ... | Option Exercise | A | 2.00 | 202,962 | 405,924 | 202,962 | |
Jun 10 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Chairman of the Boa ... | Option Exercise | C | 0.00 | 270,606 | 0 | 0 | |
Jun 10 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Chairman of the Boa ... | Buy | C | 2.00 | 126,894 | 253,788 | 46,386,071 | 46.3 M to 46.4 M (+0.27 %) |
Jun 10 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Chairman of the Boa ... | Buy | C | 2.00 | 76,755 | 153,510 | 46,259,177 | 46.2 M to 46.3 M (+0.17 %) |
Jun 10 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Chairman of the Boa ... | Buy | C | 2.00 | 78,473 | 156,946 | 46,182,422 | 46.1 M to 46.2 M (+0.17 %) |
Jun 10 2014 | DFFN | Diffusion Pharmace ... | BARER SOL J | Chairman of the Boa ... | Buy | C | 2.00 | 270,616 | 541,232 | 46,103,949 | 45.8 M to 46.1 M (+0.59 %) |
Jun 06 2014 | DFFN | Diffusion Pharmace ... | DONENBERG PHILIP B | Chief Financial Off ... | Option Exercise | A | 4.00 | 250,000 | 1,000,000 | 250,000 | |
Mar 12 2014 | DFFN | Diffusion Pharmace ... | SIMES STEPHEN M | Chief Executive Off ... | Option Exercise | A | 0.02 | 50,000,000 | 1,000,000 | 50,000,000 | |
Mar 10 2014 | DFFN | Diffusion Pharmace ... | Bright Rex | Director | Option Exercise | A | 0.03 | 1,650,000 | 49,500 | 1,650,000 | |
Jun 10 2013 | DFFN | Diffusion Pharmace ... | BLECH ISAAC | 10% Owner | Option Exercise | X | 1.00 | 8,125,000 | 8,125,000 | 0 | |
Jun 10 2013 | DFFN | Diffusion Pharmace ... | BLECH ISAAC | 10% Owner | Option Exercise | X | 0.65 | 16,250,000 | 10,562,500 | 0 | |
Jun 10 2013 | DFFN | Diffusion Pharmace ... | BLECH ISAAC | 10% Owner | Option Exercise | C | 0.06 | 6,500 | 390 | 0 | |
Jun 10 2013 | DFFN | Diffusion Pharmace ... | BLECH ISAAC | 10% Owner | Option Exercise | X | 1.00 | 625,000 | 625,000 | 0 | |
Jun 10 2013 | DFFN | Diffusion Pharmace ... | BLECH ISAAC | 10% Owner | Option Exercise | X | 0.65 | 1,250,000 | 812,500 | 0 | |
Jun 10 2013 | DFFN | Diffusion Pharmace ... | BLECH ISAAC | 10% Owner | Option Exercise | C | 0.06 | 500 | 30 | 0 | |
Jun 10 2013 | DFFN | Diffusion Pharmace ... | BLECH ISAAC | 10% Owner | Buy | X | 0.00 | 46,428,571 | 0 | 185,000,000 | 138.6 M to 185 M (+33.51 %) |
Jun 10 2013 | DFFN | Diffusion Pharmace ... | BLECH ISAAC | 10% Owner | Buy | C | 0.06 | 108,333,333 | 6,500,000 | 138,571,429 | 30.2 M to 138.6 M (+358.27 %) |